Information for Authors
Author Guidelines
The Journal of Pharmaceutical Sciences and Biomedicine provides authors with editorial and manuscript preparation instructions in a visible, accessible, and regularly updated section of its website. These guidelines must be followed by all manuscripts submitted for evaluation.
These instructions are intended to guide the preparation, submission, review, and publication of manuscripts, ensuring clarity in editorial requirements, consistency in manuscript presentation, and transparency throughout the editorial process.
Authors must ensure that their manuscript is original, unpublished, and not under simultaneous consideration by another journal. Authors must also comply with applicable ethical guidelines, disclose any potential conflicts of interest, properly acknowledge authorship contributions, obtain the necessary permissions for the use of previously published material, and address any observations arising from the editorial and peer-review process.
The journal publishes original articles, review articles, short communications, hypotheses, tutorials, letters to the editor, and editorials. Each type of contribution must comply with the specific requirements regarding length, structure, formatting, references, tables, figures, and other criteria established in these guidelines.
The author guidelines will be periodically reviewed and updated by the Editorial Committee in order to maintain their relevance, clarity, and alignment with the journal’s current editorial policies.
Types of Articles
Editorial
An editorial is an opinion or reflective article addressing current topics related to pharmaceutical sciences and biomedicine, or articles published in the journal. This type of contribution is prepared by invitation from the Editorial Committee.
Original Articles
Original articles are given priority over other types of submissions. These manuscripts report the results of original research. Each manuscript must include abstracts and keywords in both Spanish and English. The maximum length is 8,000 words, excluding references. The combined number of tables and figures must not exceed five.
Short Communications
Short communications present preliminary findings that, due to their importance, warrant further research or discussion within the scientific community. The maximum length is 3,000 words, excluding references. These manuscripts may include up to two tables or figures and an abstract of no more than 100 words. Their structure must follow the same sequence as that of original articles.
Review Articles
Review articles are manuscripts that synthesize, analyze, and discuss the existing scientific literature on a specific topic, providing a critical and updated perspective on advances, trends, and challenges in the field. They do not present original experimental results; rather, they organize and compare previous studies to identify patterns, knowledge gaps, and future research directions. The length must range from 4,000 to 10,000 words, excluding references, and may include up to five tables and/or figures.
Hypotheses
Hypothesis articles propose a new idea, model, or theory to explain a scientific phenomenon based on existing evidence. They do not present original experimental data but integrate and analyze previous information to formulate an innovative proposal that may be tested in future studies.
Tutorials
Tutorials are manuscripts designed to clearly and didactically explain a concept, methodology, or technique within a scientific field. Their objective is to guide researchers, students, or professionals in understanding and applying a given topic by providing detailed explanations, practical examples, and, when appropriate, comparisons with other approaches. Their structure generally includes an introduction to the topic, step-by-step development, examples or case studies, and a conclusion with recommendations or practical applications.
Letters to the Editor
Letters to the editor aim to stimulate discussion and feedback regarding articles previously published in the journal. The scientific community is invited to submit constructive critiques with a maximum length of 1,000 words and up to 10 references. In addition to the letter, the author’s reply will be published in the same issue of the journal.
Manuscript Preparation Instructions
All manuscripts must be submitted digitally through the journal’s website. The recommended format is Microsoft Word, using Times New Roman, font size 12, and single line spacing. For submission, the corresponding author must first register on the journal platform. In case of difficulties with the registration process, please contact: bespinosar@uanl.edu.mx.
Correspondence must be addressed to the Editor-in-Chief of the Journal of Pharmaceutical Sciences and Biomedicine. A cover letter must be submitted, specifying the corresponding author and their contact information, including affiliation, telephone number, and email address.
Manuscripts must follow the sequence below:
Front page, including title, authors, affiliations, and correspondence details.
Abstracts and keywords in English and Spanish.
Main text.
Acknowledgments.
Conflict of interest statement.
References.
Tables or figures.
1. Front Page
The front page must indicate the type of manuscript being submitted, such as original article, tutorial, hypothesis, or another applicable category. It must also include the title of the work and the full list of authors, with their names and surnames in the order in which they should appear in the publication, including their institutional affiliations.
2. Abstracts and Keywords
An abstract in Spanish must be presented on the second page, followed by an abstract in English on the third page. Each abstract must have a maximum length of 250 words.
For original articles and short communications, the abstract must follow this structure:
- Introduction
- Objectives
- Methods
- Results
- Conclusions
Three to five keywords must be provided.
3. Main Text
The main text begins on the fourth page. For research articles, it must contain the following sections:
Introduction
The introduction must include the purpose of the study and the background supporting the research.
Materials and Methods
This section must include the methods, instruments or equipment, and procedures used, with sufficient precision to allow reproducibility by other researchers.
Studies involving human participants must comply with the ethical standards of the Declaration of Helsinki, updated in 2013. Authors must explicitly indicate whether the study was reviewed and approved by a Human Research Ethics Committee of the institution where the study was conducted. Informed consent from study participants must also be mentioned.
Drugs and chemical compounds used in the study must be identified by their generic names, doses, and routes of administration.
Experiments involving animals must be conducted in accordance with the technical specifications for the production, care, and use of laboratory animals established in NOM-062-ZOO-1999, or in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health, NIH Publication No. 80-23, revised 1978.
If a crystallographic representation of a compound is included, it must be accompanied by the relevant crystallographic data, the data collection method, and the methods used for structure solution and refinement.
Sufficient evidence must be provided to confirm the identity of each compound.
All new compounds must be fully characterized with relevant and detailed spectroscopic and spectrometric data.
For physical, spectroscopic, and spectrometric data, the following general style must be used:
(3S)-7-Hydroxy-2′,3′,4′,5′,8-pentamethoxyisoflavone (1). Amorphous powder: m.p. 125–126 °C; [α]D +3.12 (c 0.320, MeOH); UV (MeOH) λmax (log ε) 218 (3.91), 284 (2.89) nm; CD (c 0.0136, MeOH): [θ]210 −2.699, [θ]226 0.4130, [θ]256 −0.8567, [θ]265.5 0.6865; IR (CHCl3) νmax 3530, 2939, 2840, 1603, 1494, 1193, 1040 cm−1; 1H NMR (CDCl3, 500 MHz) δ 6.72 (1H, dd, J5,6 = 8.5, J4α,5 = 1.0 Hz, H-5), 6.53 (1H, dd, J5,6 = 8.5 Hz, H-6), 6.40 (1H, s, H-6′), 5.80 (1H, brs, OH), 4.39 (1H, ddd, J2β,2α = 10.5, J2β,3β = 3.5, J2β,4β = 1.0 Hz, H-2′), 4.05 (1H, dd, J2β,2α = J2α,3β 10.5 Hz, H-2′), 3.95 (3H, s, CH3O-C-3′), 3.92 (3H, s, CH3O-C-8), 3.89 (3H, s, CH3-C-4′), 3.83 (3H, s, CH3O-C-2′), 3.79 (3H, s, CH3O-C-5′), 3.61 (1H, dddd, J = 10.5, 3.5, 5.5, 10.5 Hz, H-3), 2.96 (1H, ddd, J4α,4β = 16.0, J4α,3β = 10.5, J4α,5 = 1.0 Hz, H-4α), 2.90 (1H, ddd, J = 16.0, J3β,4β = 5.5, J2β,4β = 1.0 Hz, H-4′); 13C NMR (CDCl3, 125 MHz, assignments by APT and HMQC) δ 149.67 (C-5′), 147.60 (C-7), 147.15 (C-3′), 147.12 (C-8a), 145.50 (C-2′), 141.95 (C-4′), 134.80 (C-8), 128.90 (C-1′), 124.20 (C-5), 115.00 (C-4a), 107.10 (C-6), 70.28 (C-2), 61.89 (OCH3-C-4′), 61.51 (OCH3-C-2′), 61.00 (OCH3-C-3′), 60.90 (OCH3-C-8), 56.25 (OCH3-C-5′), 31.84 (C-3), 31.32 (C-4); EIMS m/z, relative intensity: 376 [M]+ (73), 224 (100), 209 (42), 152 (16), 151 (38), 121 (14). Anal. C 63.65%, H 6.68%, calculated for C20H24O7: C 63.82%, H 6.43%.
For computational results, force-field parameters and equations must be included in sufficient detail to allow readers to repeat and reproduce the calculations.
For studies involving natural products, authors must indicate whether the products are new or previously known and describe their biological activities. All active agents must be sufficiently identified by their chemical names and common names, when applicable.
Natural products must be adequately described using the Latin binomial name of the plant, fungus, animal, or microorganism. Authors must also indicate the family of the species, country and region of collection, name of the collector, voucher or registration number, and place of deposition of the study material to ensure precise identification.
For studies involving extracts and their constituents, the extraction method, dry extract yield from dry or fresh plant material, and metabolite yield must be included.
Results and Discussion
Results and discussion must be presented in a logical and coherent sequence, both in the text and in tables and figures. Data may be presented either in tables or figures, but not in both simultaneously.
Authors must highlight the novel and significant aspects contributed by the study. Agreements or discrepancies between the findings and those of other relevant studies must be clearly identified. Statements and conclusions that are not supported by the results must be avoided.
Measurements and data must be reported according to the International System of Units.
Conclusions
Authors are encouraged to include the most relevant conclusion of the study in a clear and concise manner.
4. Acknowledgments
Acknowledgments should be expressed only to individuals and institutions that made significant contributions to the work. Authors must have authorization from the individuals mentioned in the acknowledgments and are responsible for including them, as readers may interpret such mention as endorsement of the study’s results and conclusions.
This section must appear before the references.
5. Conflict of Interest Statement
Authors must include a written statement explicitly indicating whether any academic or financial relationship exists that may have an interest in the results of the research, including whether they have received monetary or material benefits.
A conflict of interest statement must be provided for each author. If relationships exist that may constitute a conflict of interest, authors must specify what they are and what they involve.
6. References
The accuracy of references is the responsibility of the authors. Authors must also ensure that all references cited in the manuscript are included in the reference list at the end of the manuscript.
References must be cited using Arabic numerals in superscript and must appear before punctuation when placed at the end of a sentence. They must be numbered sequentially in the text and in the reference list.
Only published works, in press articles, and online publications should be included. Works in progress, submitted manuscripts that have not yet been accepted, unpublished data, and personal communications may only be acknowledged parenthetically in the text, including the year.
The reference style to be used is that of the American Psychological Association, APA. Examples are shown below.
Journal Articles
Articles with up to five authors
- Bailey, C. J., & Turner, R. C. (1996). Metformin. New England Journal of Medicine, 334(9), 574–579.
Articles with more than five authors
- Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012). Cellular and molecular mechanisms of metformin: An overview. Clinical Science, 122(6), 253–270.
Books
- DiPiro, J. T., Talbert, R. L., Yee, G. C., Matzke, G. R., Wells, B. G., & Posey, L. M. (Eds.). (2014). Pharmacotherapy: A pathophysiologic approach.
Theses
- King, K. J. Development of a Pressurized System for Oxidation Studies of Volatile Fluids. Master’s thesis, The Pennsylvania State University, State College, PA, March 1983.
Patents
- Sheem, S. K. (2004). Low-Cost Fiber Optic Pressure Sensor (No. US 6,738,537). Lawrence Livermore National Laboratory, Livermore, CA, United States.
Websites
- U.S. Environmental Protection Agency. http://www.epa.gov. Accessed April 24, 2011.
7. Tables, Figures, and Schemes
The editor will prepare the final layout of all tables and figures as appropriate. All tables and figures must be mentioned in the text.
No more than five tables and/or figures will be accepted, although exceptions may be considered. Tables and figures taken from another source, either exactly reproduced or adapted, require written permission from the corresponding publisher. It is the author’s responsibility to obtain such permission for acceptance by the Journal of Pharmaceutical Sciences and Biomedicine.
Tables
Each table must be prepared on a separate page using Microsoft Word format and must be as complete and explanatory as possible.
Each table must include a title and be numbered using Arabic numerals. Only horizontal lines should be used to separate information within the table. Authors should avoid using both tables and graphs to illustrate the same results.
Superscript letters should be used to provide clarifications within tables. Explanatory notes must be placed below the corresponding table.
Figures and Schemes
Figures and schemes must be as complete and explanatory as possible and must be submitted as separate files, either in black and white or color, in high definition, at no less than 300 dpi, in PNG or TIFF format.
Each file must be named as follows: Fig. 1, Fig. 2, Scheme 1, Scheme 2, and so forth.
Editorial
Exclusive section for editors.
Submit a new manuscript to the Editorial section.
Short Communications
Preliminary research findings.
Submit a new manuscript to the Short Communications section.
Letters to the Editor
Constructive critiques of previously published articles or preliminary findings.
Submit a new manuscript to the Letters to the Editor section.
Supplement
Supplementary issue.
Submit a new manuscript to the Supplement section.
Proceedings
Conference proceedings abstracts.
Submit a new manuscript to the Proceedings section.
Copyright Notice
Authors who publish with this journal agree to the following terms:
Authors retain their copyright and grant the journal the right of first publication of the work. The work will simultaneously be subject to a Creative Commons Attribution License, which allows third parties to share the work provided that authorship and first publication in this journal are properly acknowledged.
Authors may enter into additional non-exclusive licensing agreements for the distribution of the published version of the work, such as depositing it in an institutional repository or publishing it as part of a monographic volume, provided that the initial publication in this journal is acknowledged.
Authors are permitted and encouraged to disseminate their work online, for example in institutional repositories or on their personal websites, before and during the submission process, as this may foster scholarly exchange and increase citations of the published work. See: The Effect of Open Access.
Privacy Statement
The names and email addresses entered in this journal will be used exclusively for the purposes stated by the journal and will not be made available to third parties or used for any other purpose.
The personal data voluntarily provided to this University, either electronically or in person, will be collected, protected, incorporated, and processed within the Personal Data System of the Universidad Autónoma de Nuevo León, located at Ave. Universidad s/n, Ciudad Universitaria, San Nicolás de los Garza, Nuevo León, in accordance with the Law on Transparency and Access to Information of the State of Nuevo León.
For the purposes of this statement, personal data shall be understood as any information concerning an identified or identifiable natural person, including, but not limited to, address, telephone number, ethnic origin, ideology, health status, and similar information.
The authority collecting the data shall be responsible for the personal data system. Such data will be used solely and exclusively for the purposes of each university department or unit comprising this institution, including high schools, faculties, and administrative departments. Likewise, such personal data may only be provided to authorities that duly demonstrate legal authority to request it.
Refusal to provide the personal data required by the authority and/or official will indefinitely interrupt the corresponding procedure or process to be carried out at the University.
The authenticity and updating of the data provided are the responsibility of both the data subject and the authority collecting the data.
Data subjects may exercise their rights of access, rectification, cancellation, or opposition regarding their personal data in person before the Liaison Unit for Transparency, Access to Information, and Personal Data Protection, or via the following address: http://transparencia.uanl.mx/.
Finally, regarding any changes to this Privacy Notice, the Universidad Autónoma de Nuevo León reserves the right to make modifications or updates to this notice at any time and undertakes to inform data subjects in a timely manner through appropriate means, such as the website http://www.uanl.mx/ or the email address provided to this institution.
